S EVERAL investigators have detected norepinephrine in various tissues'-6 and in Epinephrine, U.S.P., derived from the adrenal glands of cattle.7-9 The suggestion has been made repeatedly that norepinephrine may be a chemical mediator at certain adrenergic neuroeffector junctions.'' 6 7 , [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] There have appeared during the past year the first, and almost simultaneous, reports7' 14, 15 of the presence of varying amounts of norepinephrine in the human adrenal medulla and in pheochromocytomas. In a preliminary paper,'6 published at virtually the same time, we reported the presence of a large amount of a "pressor substance other than epinephrine" in a pheochromocytoma. In each of these studies different chemical and biologic methods of identification were used. We have recently assayed a second pheochromocytoma. Methods similar to ours have been used by Beyerl7 in the study of two adrenal medullary tumors.
There were distinct differences in the clinical aspects of our two cases. The first tumor (hereafter referred to as tumor A) was removed from a 13 year old white boy who had severe sustained arterial hypertension. The clinical features resembled those seen in essential hypertension, and this emphasizes the necessity for considering pheochromocytoma in the differential diagnosis of arterial hypertension. He was a ruddy complexioned, alert and well developed boy who appeared well. The arterial blood pressure measured in the arms was 212/154, the pulse rate was 120, full and regular. There The pressor responses produced by the tumor extracts may be attributed to a substance or substances either of sympathomimetic or nonsympathomimetic nature. The use of Dibenamine to differentiate these two classes of compounds rests upon its ability to block the pressor activity of sympathomimetic compounds without blocking the pressor responses to nonsympathomimetic compounds. The pressor effects of nonsympathomimetic compounds such as angiotonin and Pitressin are not blocked by Dibenamine.'820 Presumably, the site of action of these compounds is directly upon the contractile mechanism. figure 5 . In the second dog, the first injec- A pheochromocytoma which produces a sustained hypertension presumably does so by the more or less constant liberation of epinephrine or an epinephrine-like substance into the circulation. If the injection of epinephrine during or soon after the administration of Dibenamine decreases the effectiveness of the adrenergic blockade, as has been suggested by Nickerson22 afld supported by the experiments described above, the explanation of the neutralization by Dibenamine of the major part of the hypertension associated with pheochromocytomas is not readily apparent. Acute experiments were done in an attempt to simulate the sustained hypertension associated with some pheochromocytomas, and to study the effect of Dibenamine upon such hypertension.
Constant intravenous infusions of either l-epinephrine (1:25,000) or l-norepinephrine were given to three dogs by means of a powerdriv-en syringe. The rate of injection was adjuste(l until the desired level of hypertension was obtained. A dose of 15 mg. per Kg. of Dibenamine was then injected intravenously during an eight minute period. Two of the 3 dogs received l-norepinephrine infusions and the third dog received an infusion of I epinephrine. In each instance the drug infusions began 10 to 20 minutes prior to the injection of Dibenamine, and were continued throughout the period of Dibenamine administration.
One 1-norepineph rine infusion was continued for 60 minutes after Dibenamine, and the remaining l-norepinephrine and l-epinephrine infusions were continued for 20 minutes after Dibenamine. Within five minutes after the beginning of the injection of Dibenamine, the arterial blood pressure declined steadily to the pre-hypertensive level, in the case of the 1-norepinephrine infusions, and to below the prehypertensive level in the l-epinephrine infusion. If the infusions were momentarily discontinued 1 to 10 minutes after completion of Dibenamine injection, the arterial blood pressure returned to the pre-hypertensive level. When the I-norepinephrine infusions were started again at the same rate, the arterial blood pressure increased but only one-third as much as it did before Dibenamine. When the l-epinephrine infusion was started again, the arterial blood pressure fell below the pre-hypertensive level. Single injections of l-epinephrine (1 to 2 cc. 1:50,000) produced pressor responses 20 minutes after Dibenamine and slight reductions of arterial blood pressure 40 to 60 minutes after Dibenamine. Single injections of l-norepinephrine (2 cc. 1:50,000) produced consistent pressor responses when injected 20 to 60 minutes after Dibenamine.
DISCUSSION
The results of these experiments indicate that, with the time and dose relations of Dibenamine which were used, the pressor response to l-norepinephrine is not always blocked, and its effects upon the arterial blood pressure after Dibenamine are unpredictable. The failure of Dibenamine to block the pressor activity of l-norepinephrine in dosages which are considerably greater than those necessary to block and to reverse the pressor response to all doses of l-epinephrine, indicates that Dibenamine cannot be used to differentiate pressor responses due to sympathomimetic and nonsympathomimetic compounds when norepinephrine is involved. Various other adrenergic blocking agents such as N-piperdino-methylbenzodioxane (933 F), yohimbine, ergotamine, and ergotoxine are known to be less effective in blocking the pressor activity of 1-norepinephrine than of epinephrine.Y. 12, 13, [23] [24] [25] In accordance with the observations of Nickerson,22 epinephrine injected during the administration of Dibenamine, or soon after, decreases the effectiveness of the adrenergic blockade.
The findings in tumor A are compatible with the reports of the presence of norepinephrine in pheochromocytomas7 14. 15. 17, 26 to the extent that the actions of the pressor substance after Dibenamine resembled those of norepinephrine rather than epinephrine. The demonstration of norepinephrine in the adrenal medulla as well as in various adrenergic nerves strengthens the concept that this compound is an intermediary in the production of epinephrine. Two observations indicate that this is the case rather than that epinephrine is the precursor of norepinephrine. First, the epinephrine: norepinephrine ratio is higher in normal than in tumorous adrenal medullary tissue. Second, the more physiologic the conditions under which epinephrine is liberated from the adrenal medulla, the greater the proportion of epinephrine released.
The view may be restated33 that norepinephrine is concerned with epinephrine metabolism in all of the tissues which produce epinephrine. It is likely that both excitatory and inhibitory adrenergic nerves and the adrenal medulla produce epinephrine by the same steps and that the last step in the series of reactions is the conversion of norepinephrine to epinephrine. It is possible that, from all sources, some norepinephrine enters the circulation and that from some sources under certain conditions the proportion of norepinenhrine entering: the eireiilation may be increased. It is probably an oversimplification to consider that excitatory adrenergic nerves liberate only norepinephrine and inhibitory adrenergic nerves liberate only epinephrine.
SUMMARY AND CONCLUSIONS 1. Two cases of pheochromocytoma are reported. The tumors were bioassayed by comparing the effects of the tumor extracts upon the arterial blood pressure of dogs before and after the administration of the adrenergic blocking agent, Dibenamine.
2. One tumor contained predominantly a substance resembling norepinephrine. The second tumor contained chiefly an epinephrinelike substance.
3. Dibenamine is similar to other adrenergic blocking agents in its inability to block uniformly the pressor action of norepinephrine.
4. The role of norepinephrine in epinephrine metabolism is discussed.
